Showing results (211-220 of 309) with videos related to
Sort By:
Pageof 31
Leukemia|November 25, 2003
Inhibition of phosphatidylinositol 3-kinase dephosphorylates BAD and promotes apoptosis in myeloid leukemiasS Zhao, M Konopleva, M Cabreira-Hansen, et al.Leukemia|September 1, 1995
A 3-day schedule of fludarabine in previously treated chronic lymphocytic leukemiaL E Robertson, S O'Brien, H Kantarjian, et al.Current Pharmaceutical Design|August 17, 2005
Beyond single pathway inhibition: MEK inhibitors as a platform for the development of pharmacological combinations with synergistic anti-leukemic effectsM Milella, C M Precupanu, C Gregorj, et al.Leukemia|July 8, 2005
Quantitative single cell determination of ERK phosphorylation and regulation in relapsed and refractory primary acute myeloid leukemiaM R Ricciardi, T McQueen, D Chism, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1996
Telomerase activity in human acute myelogenous leukemia: inhibition of telomerase activity by differentiation-inducing agentsW Zhang, M A Piatyszek, T Kobayashi, et al.Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|March 5, 1998
Rescue from apoptosis in early (CD34-selected) versus late (non-CD34-selected) human hematopoietic cells by very late antigen 4- and vascular cell adhesion molecule (VCAM) 1-dependent adhesion to bone marrow stromal cellsM W Wang, U Consoli, C M Lane, et al.Leukemia|April 24, 1999
Quantitation of minimal residual disease in acute myelogenous leukemia and myelodysplastic syndromes in complete remission by molecular cytogenetics of progenitor cellsH Engel, J Drach, A Keyhani, et al.Leukemia & Lymphoma|March 1, 1996
Disseminated intravascular coagulation in adult acute lymphoblastic leukemia: frequent complications with fibrinogen levels less than 100 mg/dlA Sarris, J Cortes, H Kantarjian, et al.Blood|April 15, 1991
Results of a randomized trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemiaE Berman, G Heller, J Santorsa, et al.Journal of Clinical Apheresis|December 18, 2001
Donor lymphocyte apheresis for adoptive immunotherapy compared with blood stem cell apheresisM Körbling, S Giralt, I Khouri, et al.Pageof 31